Question 1

How many shares of TBPH does D. E. Shaw & Co., Inc. own?

Accepted Answer

As of 2026-Q1, D. E. Shaw & Co., Inc. holds 954,042 shares of TBPH (THERAVANCE BIOPHARMA INC).

Question 2

What is D. E. Shaw & Co., Inc.'s TBPH position worth?

Accepted Answer

As of 2026-Q1, D. E. Shaw & Co., Inc.'s TBPH position is worth $15.5M.

Question 3

Is D. E. Shaw & Co., Inc. buying or selling TBPH?

Accepted Answer

In 2026-Q1, D. E. Shaw & Co., Inc. decreased their TBPH position (-24.3% change in shares).

Question 4

When did D. E. Shaw & Co., Inc. first buy TBPH?

Accepted Answer

Based on available 13F filings, D. E. Shaw & Co., Inc. first reported a position in TBPH in 2024-Q2. They have held the position across 29 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Decreased	954,042	-24.3%	$15.5M	0.0%	$13.96	0
2025-Q4	Increased	1.3M	+4.2%	$23.6M	0.0%	$18.91	30
2025-Q3	Increased	1.2M	+20.7%	$17.7M	0.0%	$14.43	34
2025-Q2	Increased	1M	+8.8%	$11M	0.0%	$11.22	30
2025-Q1	Increased	920,302	+10.4%	$8.2M	0.0%	$9.23	30
2024-Q4	Increased	833,943	+9.1%	$7.8M	0.0%	$9.47	30
2024-Q3	Increased	764,765	+0.9%	$6.2M	0.0%	$8.10	27
2024-Q2	Decreased	758,080	-3.0%	$6.4M	0.0%	$8.48	0

TBPHShowing 8 of 29 quarters

TBPH
Showing 8 of 29 quarters